🔎 Trials Near Me

Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Virginia › Alexandria

Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Alexandria, VA keessatti

Qorannoo 11 Kansara Qara'a Non-Small Cell f Alexandria fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • Kaiser Permanente-Caton Hill Medical Center, Woodbridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Namoota walitti qabaa jiraSadarkaa 3
  • Maryland Oncology Hematology, PA, Brandywine · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Maryland Oncology Hematology, P.A., Brandywine · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07222566

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Fort Belvoir · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06357533

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Namoota walitti qabaa jiraSadarkaa 2/3
  • Local Institution - 007-814-A, Alexandria
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04613596

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Brandywine · Miili 13 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07291037

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Fort Belvoir · Miili 8 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06350097

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Inova Alexandria Hospital, Alexandria
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06500481

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Kaiser Permanente-Caton Hill Medical Center, Woodbridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Kaiser Permanente-Caton Hill Medical Center, Woodbridge · Miili 15 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Kaiser Permanente-Caton Hill Medical Center, Woodbridge · Miili 15 fagaatti
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti

Qorannoo biroo Alexandria keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.